KJIM :: Korean Journal of Internal Medicine

Utility of fecal calprotectin in the diagnosis of inflammatory bowel diseases

María Paula Armas-Ingavélez, Edison Arturo Galárraga-Pérez

Salud, Ciencia y Tecnología.2025; 5: 1125. CrossRef

Validation of rapid fecal calprotectin assay using particle enhanced turbidimetric immunoassay for inflammatory bowel disease

Akihiko Oka, Kousaku Kawashima, Kenichi Kishimoto, Satoshi Kotani, Mai Fukunaga, Nobuhiko Fukuba, Yoshiyuki Mishima, Naoki Oshima, Norihisa Ishimura, Muyiwa Awoniyi, Shunji Ishihara

Fecal calprotectin is a novel biomarker to predict the clinical outcomes of patients with ruptured intracranial aneurysm

Jun-Da Shen, Bin Yuan, An Zhang, Xiao-Ming Zhou, Shu-Juan Chen, Jin-Long Deng, Xin Zhang, Hai-Yang Jiang, Qing Yu, Qi Wu

Journal of Stroke and Cerebrovascular Diseases.2024; 33(4): 107634. CrossRef

Assessment of IBD disease activity by Interleukin-6 and serum amyloid A in relation with fecal calprotectin and endoscopic indices

Ahmed Bahaa, Tamer Elbaz, Hesham Elmakhzangy, Mohammed Shehata, Dalia Abd El-Kareem, AbdelAziz Gaber, Mohamed B. Hashem, Maissa El Raziky

Arab Journal of Gastroenterology.2024; 25(3): 299. CrossRef

Difficulties in diagnosing non-IgE-dependent gastrointestinal forms of food allergy: How informative is fecal calprotectin?

I. N. Zakharova, I. V. Berezhnaya, D. K. Dmitrieva, E. V. Skorobogatova

Meditsinskiy sovet = Medical Council.2024; (11): 138. CrossRef

Efficacy and Safety of Anthocyanin-Rich Extract in Patients with Ulcerative Colitis: A Randomized Controlled Trial

Luc Biedermann, Michael Doulberis, Philipp Schreiner, Ole Haagen Nielsen, Frans Olivier The, Stephan Brand, Sabine Burk, Petr Hruz, Pascal Juillerat, Claudia Krieger-Grübel, Kristin Leu, Gabriel E. Leventhal, Benjamin Misselwitz, Sylvie Scharl, Alain Scho

Ajit Sood, Arshdeep Singh, Ramit Mahajan, Vandana Midha, Charles N Bernstein, David T Rubin

Inflammatory Bowel Diseases.2023; 29(8): 1317. CrossRef

Clinical value of fecal calprotectin for evaluating disease activity in patients with Crohn’s disease

Junrong Li, Mingyang Xu, Wei Qian, Fangmei Ling, Yidong Chen, Shuang Li, Yiyu Cheng, Liangru Zhu

Personalized Treatment for Crohn’s Disease: Current Approaches and Future Directions

Clinical and Experimental Gastroenterology.2023; Volume 16: 249. CrossRef

Fecal Calprotectin Is a Predictor of Need for Rescue Therapy in Hospitalized Severe Colitis

Saranya Sasidharan, Alexa N Sasson, Kevin M Shannon, Ashwin N Ananthakrishnan

Inflammatory Bowel Diseases.2022; 28(12): 1833. CrossRef

Value of Fecal Calprotectin Measurement During the Initial Period of Therapeutic Anti-Tubercular Trial

Hyeong Ho Jo, Eun Young Kim, Jin Tae Jung, Joong Goo Kwon, Eun Soo Kim, Hyun Seok Lee, Yoo Jin Lee, Kyeong Ok Kim, Byung Ik Jang

Serum Calprotectin as a Blood-Based Biomarker for Monitoring Knee Osteoarthritis at Early but Not Late Stages

Amin Safa, Abolfazl Bagherifard, Hamadalla Hadi Al-Baseesee, Azade Amini Kadijani, Hooman Yahyazadeh, Masoumeh Azizi, Abolfazl Akbari, Alireza Mirzaei

Assessing adherence to objective disease monitoring and outcomes with adalimumab in a real-world IBD cohort

A. Al Khoury, Y. Xiao, P.A. Golovics, R. Kohen, W. Afif, G. Wild, G. Friedman, P. Galiatsatos, N. Hilzenrat, A. Szilagyi, J. Wyse, A. Cohen, A. Bitton, T. Bessissow, P.L. Lakatos

Digestive and Liver Disease.2021; 53(8): 980. CrossRef

Surrogate markers of mucosal healing in inflammatory bowel disease: A systematic review

Monica State, Lucian Negreanu, Theodor Voiosu, Andrei Voiosu, Paul Balanescu, Radu Bogdan Mateescu

World Journal of Gastroenterology.2021; 27(16): 1828. CrossRef

Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis

Mariusz A. Bromke, Katarzyna Neubauer, Radosław Kempiński, Małgorzata Krzystek-Korpacka

Journal of Clinical Medicine.2021; 10(10): 2203. CrossRef

Association of Fecal Calprotectin With Endoscopic and Histologic Activity in Pediatric Inflammatory Bowel Disease

Erin Crawford, Catherine Gestrich, Sindhoosha Malay, Denise Young, Sharon Perry, Judy Splawski, Thomas J. Sferra, Shahrazad Saab, Jonathan Moses

Optimal Range of Fecal Calprotectin for Predicting Mucosal Healing in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Journal of Clinical Medicine.2021; 11(1): 159. CrossRef

ROLE OF FECAL CALPROTECTIN IN DIFFERENTIATION OF INFLAMMATORY BOWEL DISEASES IN PATIENTS COMPLAINING OF ABDOMINAL SYMPTOMS AND REFERRED FOR COLONOSCOPY

Trifa Mahmood, Mohammed Mohammed, Dana Gharib, Taha Mohamad, Muhsin Mohammed, Araz Rahim

JOURNAL OF SULAIMANI MEDICAL COLLEGE.2021; 11(1): 33. CrossRef

Fecal calprotectin predicts complete mucosal healing in patients with ulcerative colitis: Systematic review and meta‑analysis

Zhongsheng Cao, Chenglong Ye, Lunan Li, Xiaoge Geng, Wensheng Pan, Jiyong Jing

World Academy of Sciences Journal.2021;[Epub] CrossRef

Dynamic changes in gut microbiota under the influence of smoking and TNF-α-blocker in patients with ankylosing spondylitis

Clinical Rheumatology.2020; 39(9): 2653. CrossRef

Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults

Małgorzata Krzystek-Korpacka, Radosław Kempiński, Mariusz Bromke, Katarzyna Neubauer

Fecal calprotectin: current and future perspectives for inflammatory bowel disease treatment

Lorenzo Bertani, Maria Gloria Mumolo, Gherardo Tapete, Eleonora Albano, Giovanni Baiano Svizzero, Federico Zanzi, Linda Ceccarelli, Massimo Bellini, Santino Marchi, Francesco Costa

European Journal of Gastroenterology & Hepatology.2020; 32(9): 1091. CrossRef

Age-Related Fecal Calprotectin Concentrations in Healthy Adults

The Korean Journal of Clinical Laboratory Science.2020; 52(3): 181. CrossRef

Assessment of disease activity in inflammatory bowel diseases: Non-invasive biomarkers and endoscopic scores

Bruno Lima Rodrigues, Márcia Carolina Mazzaro, Cristiane Kibune Nagasako, Maria de Lourdes Setsuko Ayrizono, João José Fagundes, Raquel Franco Leal

World Journal of Gastrointestinal Endoscopy.2020; 12(12): 504. CrossRef

Fecal calprotectin in daily practice for patients with inflammatory bowel disease: where do we stand in Korea?

The Korean Journal of Internal Medicine.2019; 34(1): 60. CrossRef

From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting

Maria Gloria Mumolo, Lorenzo Bertani, Linda Ceccarelli, Gabriella Laino, Giorgia Di Fluri, Eleonora Albano, Gherardo Tapete, Francesco Costa

World Journal of Gastroenterology.2018; 24(33): 3681. CrossRef

Recent advances in ankylosing spondylitis: understanding the disease and management